New concentrated, microencapsulated vitamin K2 ingredient announced by Kappa Bioscience
According to the company and its U.S. distributor AIDP, the new 1% version provides formulating, storage, and cost-in-use advantages.
Photo © Shutterstock.com/photographyfirm
Vitamin K2 supplier Kappa Bioscience AS (Oslo, Norway) has introduced a new 1% high-concentrate version of its K2Vital Delta ingredient. The K2Vital Delta line comprises microencapsulated vitamin K2 MK-7.
Says the company in a press release: “Microencapsulation protection is critical for vitamin K2 when it is formulated with minerals such as calcium or magnesium. In 2012, Kappa Bioscience discovered that K2 degrades in the presence of minerals, and many K2 consumer products were not shelf-stable. With the help of BASF’s beadlet technology, Kappa launched microencapsulated K2Vital Delta in a 0.2% format in 2013. Delta has gained wide acceptance in a range of dosage forms and global sales are estimated to be at approximately 12% of the K2 market.”
According to the company and its U.S. distributor AIDP (City of Industry, CA), the new 1% version provides formulating, storage, and cost-in-use advantages.
